• Questions? Call 0086-10-59367244
Current position Home > Co-Publications


Share |

Annual Report on Rule of Law on Health in China No. 1 (2021)


By:Su Chen, He Tian

Publisher:Social Sciences Academic Press


Publication Date:2022-01-20


2140 1000

Table of contents:

About the author(s):


Annual Report on Rule of Law on Health in China No.1 (2021),in the context of the new era,focuses on the hot issues of the rule of law in terms of medical health institutions,medical staff,basic medical insurance,healthy aging,traditional Chinese medicine and other aspects,and summarizes China’s exploration and experience in the development of the rule of law on health in recent years.

The General Report,based on the whole country,systematically sorts out the reform of the rule of law in such sectors as medical care and health,medical security,medical administration service and law enforcement supervision in recent years,and points out the problems in legislation,supervision,service and justice. It is suggested in the report that many prospects covering development in the construction of scientific and complete system of health law and regulation,a system of health law enforcement and supervision,and an organic combination of health law publicity and health science popularization are discussed.

The Blue Book launches national-level research reports on the overall situation of the medical and health security system,the development of tobacco control law,health aging,and the legal governance of food and drugs,and on long-term care insurance,drug authorization and introduction,and other issues related to people’s livelihood protection that have received wide attention from all walks of life.

For the rule of law in medical and health care,judicial proceedings and diversified dispute resolution are of great significance on multiple levels such as implementation,accountability,rights protection,and order maintenance. This volume of Blue Book sets up a special section,and researches and summarizes it based on cases,documents and data.